Veridian Healthcare supplier risk profile Q1 2026: China-heavy sourcing, 87 shipments, C-grade assessment.
Veridian Healthcare processed 87 shipments in Q1 2026 across 22 suppliers in four countries. China dominates the sourcing footprint, accounting for 95.4% of shipments, followed by India, Sri Lanka, and Singapore. Foshan Aqua Gel Biotech is the primary supplier at 62 shipments, with Guangdong Transtek Medical Electron as a secondary source at 4 shipments. The company's supply network extends to tier-2 and tier-3 suppliers, with 33 and 45 entities respectively identified in the supplier graph.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
One name matching sanctions watchlists was detected in the import records. No suppliers registered direct Uighur Forced Labor Prevention Act (UFLPA) exposure in the sourcing data.
22 distinct tier-1 suppliers in Q1 2026
| FOSHAN AQUA GEL BIOTECH | China | 62 |
| GUANGDONG TRANSTEK MEDICAL ELECTRON | China | 4 |
| UMENDRA | India | 2 |
| GUANGZHOU BERRCOM MEDICAL DEVICE | China | 1 |
| HANYU ELECTRONIC TECHNOLOGY | China | 1 |
| HONSUN NANTONG | China | 1 |
| INTERMED LABORATORIES PRIVATE | Sri Lanka | 1 |
| INTERMED LABORATORIES PRIVATE LIMIT | Singapore | 1 |
Share of Q1 2026 inbound shipments by source country
33 tier-2 + 45 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.